Market Tracker

07/28 4:36am ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.68
Delayed Data
As of Jul 27
 +0.04 / +1.52%
Today’s Change
1.65
Today|||52-Week Range
4.69
+7.20%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close2.64
Today’s open2.75
Day’s range2.61 - 2.83
Volume173,067
Average volume (3 months)258,841
Market cap$53.0M
Dividend yield--
Data as of 07/27/2017

Growth & Valuation

Earnings growth (last year)+9.64%
Earnings growth (this year)+42.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+105.25%
P/E ratioNM
Price/Sales1.60
Price/Book7.65

Competitors

 Today’s
change
Today’s
% change
JNPJuniper Pharmaceutic...0.000.00%
FCSCFibrocell Science In...+0.01+0.28%
PLXPPLX Pharma Inc-0.15-2.50%
OVASOvaScience Inc-0.03-1.96%
Data as of 07/27/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$19.9M
Annual profit (last year)-$19.1M
Net profit margin-95.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Chief Operating Officer
Clayton D. Edwards
Corporate headquarters
San Diego, California

Forecasts